- Home
- AKA vs OVID Comparison
AKA vs OVID Comparison
Compare AKA & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AKA | OVID |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.4M | 365.5M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | AKA | OVID |
|---|---|---|
| Price | $10.34 | $2.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $24.33 | $4.60 |
| AVG Volume (30 Days) | 2.6K | ★ 4.6M |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.90 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $600,208,000.00 | $7,252,000.00 |
| Revenue This Year | $6.14 | N/A |
| Revenue Next Year | $4.89 | $22.53 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 4.44 | ★ 1181.27 |
| 52 Week Low | $7.00 | $0.27 |
| 52 Week High | $16.38 | $3.11 |
Technical Indicators
Market Signals| Indicator | AKA | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 52.87 | 64.63 |
| Support Level | $8.94 | $1.31 |
| Resistance Level | $10.53 | $3.11 |
| Average True Range (ATR) | 0.54 | 0.22 |
| MACD | 0.10 | 0.03 |
| Stochastic Oscillator | 46.31 | 72.81 |
Price Performance
Historical ComparisonAbout AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is a portfolio of fashion brands, including Princess Polly, Culture Kings, Petal & Pup, and mnml. Through these brands, the company reaches next-generation consumers who seek fashion inspiration on social media and mainly shop online. The portfolio consists of two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company generates the majority of its revenue from the United States.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.